Role of ERK, p38 and PI3-kinase in EGF receptor-mediated mitogenic signalling in cultured rat hepatocytes: Requirement for sustained ERK activation

Cellular Physiology and Biochemistry

Volumn 13, Issue 4, 2003, Pages 229-238

  Thoresen, G Hege ^a,b   Guren, Tormod K ^a   Christoffersen, Thoralf ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

DNA synthesis; EGF; ERK; Hepatocyte; p38; PI3 kinase; TGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN INHIBITOR; PROTEIN P13; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; LIVER CELL; MALE; MITOGENICITY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT;

EID: 0038093151     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072426     Document Type: Article

References (51)

1. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001;410;37-40.
2. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 1998;74:49-139.
3. Wilkinson MG, Millar JBA: Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J 2000;14:2147-2157.
4. Pearson G, Robinson F, Gibson TB, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-183.
5. Brunet A, Pouysségur J: Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem 1997;32:1-16.
6. Cobb MH: MAP kinase pathways. Prog Biophys Mol Biol 1999;71:479-500.
7. Band CJ, Mounier C, Posner BI: Epidermal growth factor and insulin-induced deoxyribonucleic acid synthesis in primary rat hepatocytes is phosphatidylinositol 3-kinase dependent and dissociated from protooncogene induction. Endocrinology 1999;140:5626-5634.
8. Kong M, Mounier C, Wu J, Posner BI: Epidermal growth factor-induced phosphatidylinositol 3-kinase activation and DNA synthesis. Identification of Grb2-associated binder 2 as the major mediator in rat hepatocytes. J Biol Chem 2000;275:36035-36042.
9. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80;179-185.
10. Meloche S, Seuwen K, Pagès G, Pouysségur J: Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol 1992;6:845-854.
11. Cook SJ, McCormick F: Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem J 1996;320:237-245.
12. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P: The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 1998;330:1451-1460.
13. Cook SJ, Aziz N, McMahon M: The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol 1999;19:330-341.
14. Tsukada Y, Miyazawa K, Kitamura N: High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 2001;276:40968-40976.
15. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BMJ: T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 1997;272:15023-15027.
16. Potapova O, Gorospe M, Bost F, Dean NM, Gaarde WA, Mercola D, Holbrook NJ: c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J Biol Chem 2000;275:24767-24775.
17. Michalopoulos GK: Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176-187.
18. Christoffersen T, Thoresen GH, Dajani OF, Melien Ø, Guren TK, Refsnes M, Sandnes D: Mechanisms of hepatocyte growth regulation by hormones and growth factors; in Berry MN, Edwards AM (eds): The Hepatocyte Review. Dortrecht, Kluwer Academic Publisher, 2000, pp. 209-246.
19. Sand TE, Christoffersen T: Temporal requirement for epidermal growth factor and insulin in the stimulation of hepatocyte DNA synthesis. J Cell Physiol 1987;131:141-148.
20. 1 . J Biol Chem 1996;271:11484-11492.
21. MAP kinase in adult rat hepatocytes. FEBS Lett 1997;412:9-14.
22. Thoresen GH, Guren TK, Sandnes D, Peak M, Agius L and Christoffersen T: Response to transforming growth factor α(TGFα) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGFα is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J Cell Physiol 1998;175:10-18.
23. Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C, Baffet G: Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol Biol Cell 2001;12:725-738.
24. Spector MS, Auer KL, Jarvis WD, Ishac EJN, Gao B, Kunos G, Dent P: Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol 1997;17:3556-3565.
25. Chen J, Ishac EJN, Dent P, Kunos G, Gao B: Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem J 1998;334:669-676.
26. Dixon M, Agius L, Yeaman SJ, Day CP: Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase. Hepatology 1999;29:1418-1424.
27. 1 phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003-6011.
28. Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G: PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 2002;36:1079-1088.
29. Christoffersen T, Refsnes M, Brønstad GO, Østby E, Huse J, Haffner F, Sand TE, Hunt NH, Sonne O: Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone. Eur J Biochem 1984;138:217-226.
30. 3 H1 myocytes by fluoroaluminate. J Biol Chem 1991;266:10131-10135.
31. Harlow E, Lane D: Antibodies: a laboratory manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1988.
32. Guren TK, Thoresen GH, Dajani OF, Taraldsrud E, Moberg ER, Christoffersen T: Epidermal growth factor behaves as a partial agonist in hepatocytes: effects on DNA synthesis in primary culture and competition with transforming growth factor α. Growth factors 1996;13:171-179.
33. Ruff-Jamison S, McGlade J, Pawson T, Chen K, Cohen S: Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. J Biol Chem 1993;268;7610-7612.
34. van der Geer P, Wiley S, Lai VKM, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T: A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr Biol 1995;5:404-412.
35. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-7689.
36. Nilssen LS, Thoresen GH, Christoffersen T, Sandnes D: Differential role of MAP kinases in stimulation of hepatocyte growth by EGF and G-protein-coupled receptor agonists. Biochem Biophys Res Commun 2002;291:588-592.
37. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-233.
38. Kumar S, Jiang MS, Adams JL, Lee JC: Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 1999;263:825-831.
39. MAPK cascade. J Biol Chem 1999;274:19593-19600.
40. Zhang H, Shi X, Hampong M, Blanis L, Pelech S: Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem 2001;276:6905-6908.
41. Westermarck J, Li SP, Kallunki T, Han J, Kahari VM: p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol 2001;21:2373-2383.
42. Roche S, Koegl M, Courtneidge SA: The phosphatidylinositol 3-kinase á is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 1994;91:9185-9189.
43. Kong M, Mounier C, Dumas V, Posner BI: Epidermal growth factor-induced DNA synthesis: key role for Src phosphorylation of the docking protein Gab2. J Biol Chem 2003;278:5837-5844.
44. Ui M, Okada T, Hazeki K, Hazeki O: Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995;20:303-307.
45. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269;5241-5248.
46. 1 phase. Biochem J 1997;326:61-68.
47. Cip1 . Mol Cell Biol 1997;17:5588-5597.
48. Cip1 . Mol Cell Biol 1997;17:5589-5611.
49. Hazzalin CA, Mahadevan LC: MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 2002;3:30-40.
50. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001;70:535-602.
51. Skouteris GG, Georgakopoulos E: Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 1996;218:229-233.